SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+1.37%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$451M
AUM Growth
+$451M
(+39%)
Cap. Flow
+$52.2M
Cap. Flow
% of AUM
11.58%
Top 10 Holdings %
Top 10 Hldgs %
37.93%
Holding
109
New
31
Increased
24
Reduced
17
Closed
18
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$17M |
| 2 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$16M |
| 3 |
AMN Healthcare
AMN
|
$15.9M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$14.8M |
| 5 |
Cigna
CI
|
$13.8M |
Top Sells
| 1 |
Actinium Pharmaceuticals
ATNM
|
$77.1M |
| 2 |
Merck
MRK
|
$8.84M |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$8.51M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$8.26M |
| 5 |
Eli Lilly
LLY
|
$7.54M |
Sector Composition
| 1 | Healthcare | 83.97% |
| 2 | Consumer Staples | 0.92% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR Gold Trust
GLD
$107B
| $22.7M | 4.5% | 128,202 +7,500 | +6% | +$1.33M |
|
2
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $19.2M | 3.79% | 1,044,161 -91,702 | -8% | -$1.68M |
|
3
McKesson
MCK
$85.4B
| $17.6M | 3.49% | 118,449 +21,164 | +22% | +$3.15M |
|
|
4
Johnson & Johnson
JNJ
$427B
| $17M | 3.37% | +114,400 | New | +$17M |
|
|
HRC
5
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $16.7M | 3.31% | 199,900 +109,900 | +122% | +$9.18M |
|
|
ALBO
6
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $16M | 3.16% | +478,624 | New | +$16M |
|
|
7
AMN Healthcare
AMN
$796M
| $15.9M | 3.15% | +272,233 | New | +$15.9M |
|
8
Cencora
COR
$56.5B
| $15.9M | 3.15% | 163,871 +63,326 | +63% | +$6.14M |
|
9
Cardinal Health
CAH
$35.5B
| $15.1M | 3% | 322,480 +188,980 | +142% | +$8.87M |
|
|
10
BioMarin Pharmaceuticals
BMRN
$11.2B
| $14.8M | 2.93% | +194,744 | New | +$14.8M |
|
|
11
Cigna
CI
$80.3B
| $13.8M | 2.73% | +81,415 | New | +$13.8M |
|
12
HCA Healthcare
HCA
$94.5B
| $13.2M | 2.62% | 105,932 +24,200 | +30% | +$3.02M |
|
13
Molina Healthcare
MOH
$9.8B
| $12M | 2.38% | 65,774 +8,967 | +16% | +$1.64M |
|
|
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.5M | 2.27% | +147,500 | New | +$11.5M |
|
|
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
| $10.8M | 2.13% | 300,094 +175,900 | +142% | +$6.32M |
|
16
Quest Diagnostics
DGX
$20.3B
| $8.59M | 1.7% | +75,000 | New | +$8.59M |
|
17
Teva Pharmaceuticals
TEVA
$21.1B
| $8.58M | 1.7% | 951,691 -11,105 | -1% | -$100K |
|
|
CBAY
18
DELISTED
Cymabay Therapeutics
CBAY
| $8.39M | 1.66% | 1,159,236 -1,140,746 | -50% | -$8.26M |
|
|
RDUS
19
DELISTED
Radius Health, Inc.
RDUS
| $7.88M | 1.56% | 694,770 +332,368 | +92% | +$3.77M |
|
|
SOLY
20
DELISTED
Soliton, Inc.
SOLY
| $7.83M | 1.55% | 1,025,000 | – | – |
|
21
GSK
GSK
$79.9B
| $7.78M | 1.54% | +206,638 | New | +$7.78M |
|
22
Integer Holdings
ITGR
$3.78B
| $7.63M | 1.51% | +129,376 | New | +$7.63M |
|
|
VRAY
23
DELISTED
ViewRay, Inc.
VRAY
| $7.13M | 1.41% | 2,038,175 +743,385 | +57% | +$2.6M |
|
24
Orthofix Medical
OFIX
$592M
| $6.79M | 1.34% | 217,917 +26,026 | +14% | +$810K |
|
25
United Therapeutics
UTHR
$13.8B
| $5.98M | 1.18% | 59,210 -6,000 | -9% | -$606K |
|